Home
Chulabhorn Royal Academy Collaborates with Network Partners to Invite Thai Society to Care for Health and Fight Cancer, Launching the Campaign “HPV Concerns All of Us: Protect the Ones You Love!”, and Inviting “Nadech & Yaya” to Co-Campaign to Raise Awareness on HPV Prevention for All Genders
Bangkok, October 1, 2026 — Chulabhorn Hospital, Chulabhorn Royal Academy, in collaboration with key network partners, held a proactive campaign launching the “HPV Concerns All of Us: Protect the Ones You Love!” campaign. The initiative invites Thai people to embrace a new perspective that HPV is not solely an issue for women or men, but rather a matter for everyone, while promoting understanding of the disease and prevention guidelines for both genders. Held in celebration of the 20 years of HPV vaccination innovation and the approaching 17th anniversary of Chulabhorn Hospital, the event honored popular celebrity couple Nadech Kugimiya and "Yaya" Urassaya Sperbund, who joined to share insights and inspire health care in a warm atmosphere.
This event stems from a collaboration among four key network partners: Chulabhorn Hospital Chulabhorn Royal Academy, the Ministry of Health, the Royal Thai College of Obstetricians and Gynaecologists, and the Head and Neck Cancer Society of Thailand, with the aim of driving concrete efforts in preventing HPV (Human Papillomavirus)-related cancers within Thai society.
Assoc. Prof. Surasak Leelaudomlipi M.D., Acting Director of Chulabhorn Hospital, Chulabhorn Royal Academy, stated that the mission is to uphold the royal aspiration of Professor Dr. Her Royal Highness Princess Chulabhorn Krom Phra Srisavangavadhana, Founder and President of the Chulabhorn Royal Academy, who established Chulabhorn Hospital to serve as a "refuge for cancer patients." The hospital emphasizes proactive prevention, healthcare, and improving the quality of life for Thai people so they can universally access healthcare services. In the lead-up to its 17th anniversary on October 29, the hospital organized this activity to continue its commitment to promoting cancer prevention, building awareness that “HPV Concerns All of Us,” and encouraging public access to appropriate prevention for a sustainably cancer-free Thai society. Meanwhile, a representative from the Ministry of Health expressed a strong commitment to supporting and promoting proactive preventive measures, including awareness-raising, screening, and expanding access to vaccines so that the public can access HPV cancer prevention more concretely. Prof. Emeritus Sarikapan Wilailak M.D., President of the Royal Thai College of Obstetricians and Gynaecologists, noted that HPV-related diseases can be prevented at the root, and prevention is even more effective when we shift our perspective to realize that prevention is not limited to women, as men also face the risk of contracting and transmitting HPV. This aligns with Assoc. Prof. Warut Pongsapich, M.D., a representative from the Head and Neck Cancer Society of Thailand, who reflected that HPV is currently a primary cause of oral and throat cancers, ranking as the 4th most common cancer in Thai men, with continuously rising rates. Since most infected individuals are asymptomatic, they may transmit the virus unknowingly, making knowledge and risk awareness the crucial starting point for prevention.
From 20 Years of HPV Vaccines to Building Understanding That Covers Everyone
Over the past 20 years, HPV vaccines have accumulated continuous real-world data regarding efficacy and safety, with more than 100 million people receiving the vaccine worldwide. This marks a major milestone in preventing cancer and HPV-related diseases. However, societal understanding still tends to link HPV primarily to cervical cancer and women's health, even though men are also at risk of infection, transmission, and related diseases. This campaign therefore uses the 20th-anniversary milestone to broaden awareness across all genders, particularly by encouraging men to access accurate information, avoid waiting for symptoms to appear, and consult physicians regarding vaccination to assess appropriate preventive measures for themselves.
“HPV Concerns All of Us” — Time to Expand Understanding The campaign highlights that HPV is not just a women's issue. More than 90% of men who have ever had sexual intercourse are at risk of contracting HPV at some point in their lives, and the majority of infected individuals may be asymptomatic, inadvertently transmitting the virus to their partners. Furthermore, men build less immunity from infection and are prone to reinfection; being asymptomatic does not mean there is no risk. HPV is associated with several conditions in men, such as genital warts, anal cancer, and notably oral and throat cancers.
The event also featured a special Talk Show titled “HPV Concerns All of Us,” hosted by Eaky- Ekachai Euesungkomsate, alongside celebrity couple Nadech Kugimiya and Urassaya Sperbund. They added vibrancy through a Q&A session on medical insights alongside a team of specialist physicians from Chulabhorn Hospital, comprising Asst. Prof. Nuttavut Kantathavorn M.D., Head of Obstetrics and Gynecology Section, Chulabhorn Hospital, Gynecologic Oncologist and Minimally Invasive Gynecologic, Kant Buengsuchonsoontorn M.D., Urology and Men's Health Specialist, and Krit Madsalae M.D., Head of General practice & Family Medicine section, Chulabhorn Hospital, and Preventive Medicine specialist. They addressed key questions as follows:
• HPV is not just for women: The HPV vaccine helps prevent 6 diseases caused by HPV, namely cervical cancer, vaginal cancer, vulvar cancer, anal cancer, oral and throat cancers, and genital warts. More than 90% of men who have ever had sexual intercourse are at risk of contracting HPV and developing genital warts, anal cancer, and oral and throat cancers. Currently, the 9-valent HPV vaccine from the United States is a vaccine approved for use in males, making it advisable to consult a physician to evaluate the appropriateness of vaccination based on individual age and health status.
• Oral and throat cancers from HPV affect both women and men, though men are affected five times more frequently than women. Major risk factors include smoking, alcohol consumption, and HPV infection.
• Having only one partner can still lead to infection: HPV is easily transmitted through skin-to-skin contact and can remain dormant in the body for years without symptoms. Detecting the virus is not proof of infidelity, but rather a signal to care for each other's health.
• Being over 30 or having prior sexual experience still warrants vaccination: While maximum effectiveness is achieved before first sexual contact, individuals who have already had sexual experience still benefit from protection against new strains they have not yet encountered.
Nadech Kugimiya shared a message to all men: do not wait for symptoms or reminders from loved ones; start taking care of oneself and consult a physician for prevention. Meanwhile, Urassaya Sperbund added that encouraging loved ones to seek information and consult a doctor about HPV prevention is an expression of love and care that helps reduce the chance of transmitting the virus, as prevention is something done together, aligning with the concept “HPV Concerns All of Us — Protect the Ones You Love.”
HPV Situation and Statistics in Thailand: A Common Issue Across All Genders HPV (Human Papillomavirus) is a very common virus in both women and men. Although Thailand does not yet have an exact total infection figure because most people are asymptomatic and untested, data from Thai women aged 30–60 who underwent screening in 2024 showed an HPV infection rate of approximately 8.8%, or about 1 in 10 people. While most infections clear on their own, high-risk strains that persist can lead to precancerous lesions and cervical cancer. For men, data indicates that approximately 1 in 3 men test positive for genital HPV at any given time. However, statistics for women are clearer due to established cervical cancer screening systems, whereas routine population-wide HPV screening for men does not currently exist. HPV infection in men is highly significant because, aside from transmitting the virus, it is linked to cancers such as anal cancer, penile cancer, and oral and throat cancers. Nevertheless, Thailand's situation is improving thanks to effective preventive tools, including HPV vaccines, HPV testing, and HPV self-sampling. WHO data indicates that the incidence rate of cervical cancer in Thailand decreased from 18.1 to 10.3 per 100,000 women over the past 20 years, with Thailand driving toward WHO targets to eliminate cervical cancer as a public health problem.
Special Promotion for the 17th Anniversary of Chulabhorn Hospital
Throughout October 2026, in celebration of the 17th anniversary of Chulabhorn Hospital, Chulabhorn Hospital (Chulabhorn Royal Academy) is promoting HPV cancer prevention. Those interested in HPV prevention can consult a physician to receive the 9-valent HPV vaccine package (3 doses) for 15,897 Baht (5,299 Baht per dose, excluding injection fees, service fees, and physician fees). Special privileges for those receiving the first dose and paying the full service fee in a single billing cycle: the first 40 people will receive a Central Gift Card valued at 500 Baht, and the next 60 people will receive a Central Gift Card valued at 300 Baht.
Individuals wishing to consult a physician for HPV vaccination can make an appointment at the Check-up Center (Click to add LINE: https://line.me/R/ti/p/@836lrgks), 3rd floor, Zone B, Krom Phra Srisavangavadhana Building, Chulabhorn Hospital. Alternatively, stay updated on health information by adding Chulabhorn Hospital, Chulabhorn Royal Academy on LINE OA @chulabhornhospital and Facebook @chulabhornhospital
